http://globalhealthideas.org/2006/12/the-new-global-health-argonauts-entreprenuers/ Sun, 07 Mar 2010 21:11:16 +0000 http://wordpress.org/?v=2.9.1 hourly 1 http://globalhealthideas.org/2006/12/the-new-global-health-argonauts-entreprenuers/comment-page-1/#comment-249 Trends: Global Pharmaceutical Manufacturing and Investment « Technology, Health & Development Tue, 21 Aug 2007 05:58:10 +0000 http://thdblog.wordpress.com/2006/12/15/the-new-global-health-argonauts-entreprenuers/#comment-249 [...] Posted by Aman on August 20th, 2007 Conducting clinical trials overseas is nothing new, however, increasing access to capital and investment in emerging countries does appear to be relatively recent. Two new pieces (links at end) detail the move into China by pharmaceutical companies. I have covered this notion in a previous post. [...] [...] Posted by Aman on August 20th, 2007 Conducting clinical trials overseas is nothing new, however, increasing access to capital and investment in emerging countries does appear to be relatively recent. Two new pieces (links at end) detail the move into China by pharmaceutical companies. I have covered this notion in a previous post. [...]

]]> http://globalhealthideas.org/2006/12/the-new-global-health-argonauts-entreprenuers/comment-page-1/#comment-248 Aman Sat, 16 Dec 2006 01:08:24 +0000 http://thdblog.wordpress.com/2006/12/15/the-new-global-health-argonauts-entreprenuers/#comment-248 Jose, I absolutely agree with you about tracking outcomes and benefits to the larger community to see what the effect is. Perhaps I am naive, but this kind of "ethic" of giving back to the community seems to be more ingrained in some corporations in developing regions. How much more is the question. Either way at some point I believe that some of these in-country corporations will have a spill over effect that will impact the underserved. I am hopeful that R&D for some of these pharma companies will eventually lead to innovation (happenstance or purposeful) which then may lead to community benefits. Even just having the R&D infrastructure in-country is a big deal because this never existed before. We will see what happens. Jose, I absolutely agree with you about tracking outcomes and benefits to the larger community to see what the effect is. Perhaps I am naive, but this kind of “ethic” of giving back to the community seems to be more ingrained in some corporations in developing regions. How much more is the question. Either way at some point I believe that some of these in-country corporations will have a spill over effect that will impact the underserved. I am hopeful that R&D for some of these pharma companies will eventually lead to innovation (happenstance or purposeful) which then may lead to community benefits. Even just having the R&D infrastructure in-country is a big deal because this never existed before. We will see what happens.

]]> http://globalhealthideas.org/2006/12/the-new-global-health-argonauts-entreprenuers/comment-page-1/#comment-247 Jose Fri, 15 Dec 2006 23:30:44 +0000 http://thdblog.wordpress.com/2006/12/15/the-new-global-health-argonauts-entreprenuers/#comment-247 This is really great because it shows that they are moving from outsourcing processes to indigenous innovation. For the purposes of people reading this type of blog, it would be wise to track their performance on how they service their domestic health needs. It's great if they want to be the next Pfizer, but it would be nice if they focused on the needs closer to home. This is really great because it shows that they are moving from outsourcing processes to indigenous innovation. For the purposes of people reading this type of blog, it would be wise to track their performance on how they service their domestic health needs. It’s great if they want to be the next Pfizer, but it would be nice if they focused on the needs closer to home.

]]>